Ipsen Biopharmaceuticals, Inc.

Release Summary

Ipsen Biopharmaceuticals, Inc. announced that five poster presentations regarding Dysport® (abobotulinumtoxinA) will be presented at the 2017 meeting of the American Academy of Neurology (AAN).

Ipsen Biopharmaceuticals, Inc.